Apotex Health Corp (Ticker: APTX CN) is a Canadian pharmaceutical company focused on generic drugs and consumer health products. The Toronto-based company manufactures more than 800 pharmaceutical and consumer health products, serves customers in about 70 countries and employs over 6,000 people worldwide. Apotex Health listed on the Toronto Stock Exchange on June 10, 2026, offering 54.17 million common shares at CAD 24.00 per share, at the top of the amended CAD 20.00–24.00 range, raising CAD 1.30 billion, approximately $943 million.

According to published terms, the upsized offering consisted of 35.42 million primary shares and 18.75 million secondary shares, with a 15% greenshoe facility. The IPO was managed by BMO Capital Markets, Jefferies Securities, RBC Capital Markets, Scotiabank and TD Securities. Reuters reported that the transaction was the largest Toronto stock market IPO since 2021. Apotex was owned by New York private equity firm SK Capital Partners before the IPO, and SK Capital is expected to remain the majority shareholder after the listing.